Montelukast for Prevention & Treatment of OHSS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
patients with high risk for ovarian hyperstimulation will undergo a freeze‐all protocol then montelukast & dydrgesteron will be given to cases with suspected or proven ovarian hyperstimulation in one group in comparison with dydrogesteron alone in the other group.
Epistemonikos ID: 756de4ed4dadaae4e0f39c92e294cf2a647eec5c
First added on: May 21, 2024